 Marijuana Use in Perinatal Populations posted on Aug 4, 2017 |
|
|---|---|
This course qualifies as continuing education for physicians, nurses, certified health education specialists and other professionals provided by the Centers for Disease Control and its partners.
Origination Date – 06/30/2017 Expiration Date – 06/30/2021 The goal of this course is to enhance the knowledge of physicians and other healthcare providers about marijuana perceptions and usage among perinatal populations. This module will also discuss the prevalence and long-term impacts marijuana usage may have on pregnant women and their children. By enhancing their knowledge, physicians and other healthcare providers can better assess patients who use marijuana and provide informed guidance to their patients regarding marijuana use. Learning Objectives:
Developed By:
George Sam Wang, MD, FAAP  This material was supported by the American Academy of Pediatrics (AAP) and funded (in part) by the cooperative agreement FAIN: U61TS000237 along with the American College of Medical Toxicology and funded (in part) by the cooperative agreement FAIN: U61TS000238 from the Agency for Toxic Substances and Disease Registry (ATSDR).
Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications. Filed under: Marijuana, Online Course
|
|
| Marijuana Use in Adolescent Populations posted on Aug 4, 2017 |
|
This course qualifies as continuing education for physicians, nurses, certified health education specialists and other professionals provided by the Centers for Disease Control and its partners.
Origination Date – 06/30/2017 Expiration Date – 06/30/2021 The goal of this course is to enhance the knowledge of physicians and other healthcare providers about marijuana perceptions and usage among the adolescent populations. This module will also discuss the prevalence and long-term impacts marijuana usage may have on adolescent populations. By enhancing their knowledge, physicians and other healthcare providers can better assess patients who may suffer symptoms caused by marijuana use and provide informed guidance to their patients and caregivers regarding marijuana use. Learning Objectives:
Developed By:
George Sam Wang, MD, FAAP This material was supported by the American Academy of Pediatrics (AAP) and funded (in part) by the cooperative agreement FAIN: U61TS000237 along with the American College of Medical Toxicology and funded (in part) by the cooperative agreement FAIN: U61TS000238 from the Agency for Toxic Substances and Disease Registry (ATSDR).
Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications. Filed under: Marijuana, Online Course
|
|
| Marijuana Exposure in Pediatric Populations posted on Apr 25, 2017 |
|
This course qualifies for Continuing Education for Physicians, Nurses, Certified Health Education Specialists and Other Professionals provided by the Centers for Disease Control and its partners.
CE Origination Date – 04/19/17 The goal of this course is to enhance the knowledge of physicians and other healthcare providers about the health impacts of marijuana exposure among the pediatric population. By enhancing their knowledge, physicians and other healthcare providers can better assess pediatric patients who may suffer symptoms caused by marijuana exposure, provide informed guidance to their patients' caregivers, and advocate for stronger legislation to support exposure prevention. Learning Objectives
Developed By
George Sam Wang, MD, FAAP This material was supported by the American Academy of Pediatrics (AAP) and funded (in part) by the cooperative agreement FAIN: U61TS000237 along with the American College of Medical Toxicology and funded (in part) by the cooperative agreement FAIN: U61TS000238 from the Agency for Toxic Substances and Disease Registry (ATSDR).
Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications. Filed under: Marijuana, Online Course
|
 RSS |